1099 Stock Overview
Engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Sinopharm Group Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$20.60 |
| 52 Week High | HK$23.65 |
| 52 Week Low | HK$16.02 |
| Beta | 0.86 |
| 11 Month Change | 3.10% |
| 3 Month Change | 16.12% |
| 1 Year Change | 6.08% |
| 33 Year Change | 12.32% |
| 5 Year Change | -20.31% |
| Change since IPO | -35.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1099 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -0.2% | -1.5% | -0.6% |
| 1Y | 6.1% | -27.6% | 9.6% |
Return vs Industry: 1099 exceeded the Hong Kong Healthcare industry which returned -27.6% over the past year.
Return vs Market: 1099 underperformed the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 1099 volatility | |
|---|---|
| 1099 Average Weekly Movement | 6.1% |
| Healthcare Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 1099 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1099's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 113,635 | Wanyong Lian | www.sinopharmgroup.com.cn |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.
Sinopharm Group Co. Ltd. Fundamentals Summary
| 1099 fundamental statistics | |
|---|---|
| Market cap | HK$64.29b |
| Earnings (TTM) | HK$9.29b |
| Revenue (TTM) | HK$634.10b |
6.9x
P/E Ratio0.1x
P/S RatioIs 1099 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1099 income statement (TTM) | |
|---|---|
| Revenue | CN¥590.35b |
| Cost of Revenue | CN¥543.16b |
| Gross Profit | CN¥47.18b |
| Other Expenses | CN¥38.53b |
| Earnings | CN¥8.65b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.77 |
| Gross Margin | 7.99% |
| Net Profit Margin | 1.47% |
| Debt/Equity Ratio | 78.1% |
How did 1099 perform over the long term?
See historical performance and comparison